A Case of Vanishing Bile Duct Syndrome after Drug-Induced Liver Injury Caused by Pelubiprofen
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Bak, Haein | - |
dc.contributor.author | Kim, Hayeon | - |
dc.contributor.author | Lee, Sieun | - |
dc.contributor.author | Lee, Yoonseok | - |
dc.contributor.author | Bang, Soo-Min | - |
dc.contributor.author | Lee, Young-Sun | - |
dc.date.accessioned | 2021-08-30T06:11:33Z | - |
dc.date.available | 2021-08-30T06:11:33Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2020-12 | - |
dc.identifier.issn | 0513-5796 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/50889 | - |
dc.description.abstract | Vanishing bile duct syndrome (VBDS) is a rare disease characterized by ductopenia and cholestasis, and is linked to immunological damage to the bile duct system. VBDS can be triggered by infection, ischemia, autoimmune diseases, adverse drug reactions, and humoral factors associated with malignancy. A few cases of VBDS associated with nonsteroidal anti-inflammatory drug-related drug-induced liver injury (DILI) have been reported. Here, we report a case of a 29-year-old patient who developed DILI that progressed to VBDS after the administration of pelubiprofen. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | YONSEI UNIV COLL MEDICINE | - |
dc.title | A Case of Vanishing Bile Duct Syndrome after Drug-Induced Liver Injury Caused by Pelubiprofen | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Young-Sun | - |
dc.identifier.doi | 10.3349/ymj.2020.61.12.1060 | - |
dc.identifier.scopusid | 2-s2.0-85097036382 | - |
dc.identifier.wosid | 000595535600010 | - |
dc.identifier.bibliographicCitation | YONSEI MEDICAL JOURNAL, v.61, no.12, pp.1060 - 1063 | - |
dc.relation.isPartOf | YONSEI MEDICAL JOURNAL | - |
dc.citation.title | YONSEI MEDICAL JOURNAL | - |
dc.citation.volume | 61 | - |
dc.citation.number | 12 | - |
dc.citation.startPage | 1060 | - |
dc.citation.endPage | 1063 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002648305 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordAuthor | Pelubiprofen | - |
dc.subject.keywordAuthor | vanishing bile duct syndrome | - |
dc.subject.keywordAuthor | bile duct disease | - |
dc.subject.keywordAuthor | drug-induced liver | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.